These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7840336)

  • 21. Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat.
    Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D; Hall O
    Endocrinology; 1978 Jul; 103(1):133-40. PubMed ID: 744064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable renal atrial natriuretic factor gene expression in hypertension.
    Ogawa T; Linz W; Schölkens BA; de Bold AJ
    Hypertension; 1999 Jun; 33(6):1342-7. PubMed ID: 10373213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
    Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
    J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial performance of STZ-diabetic DOCA-hypertensive rats.
    Dai S; McNeill JH
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension differentially affects the expression of the gap junction protein connexin43 in cardiac myocytes and aortic smooth muscle cells.
    Haefliger JA; Castillo E; Waeber G; Aubert JF; Nicod P; Waeber B; Meda P
    Adv Exp Med Biol; 1997; 432():71-82. PubMed ID: 9433513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats.
    Fareh J; Touyz RM; Schiffrin EL; Thibault G
    J Mol Cell Cardiol; 2000 Apr; 32(4):665-76. PubMed ID: 10756122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic response to magnesium administration in mineralocorticoid-salt and two-kidney, one clip renovascular hypertension.
    DiPette DJ; Simpson K; Rogers A; Holland OB
    J Hypertens; 1988 May; 6(5):413-7. PubMed ID: 3385207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Afferent arteriolar diameter in DOCA-salt and two-kidney one-clip hypertensive rats.
    Iversen BM; Mørkrid L; Ofstad J
    Am J Physiol; 1983 Dec; 245(6):F755-62. PubMed ID: 6362430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of dietary salt and plasma renin activity on myosin heavy chain gene expression in rat hearts.
    Buttrick P; Kaplan M; Camargo MJ; deSimone G; Laragh JH; Wallerson D; Devereux RB
    Am J Hypertens; 1993 Jul; 6(7 Pt 1):579-85. PubMed ID: 8397998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo regulation of the beta-myosin heavy chain gene in hypertensive rodent heart.
    Wright CE; Bodell PW; Haddad F; Qin AX; Baldwin KM
    Am J Physiol Cell Physiol; 2001 May; 280(5):C1262-76. PubMed ID: 11287340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isomyosin transitions in ventricles of aldosterone-salt hypertensive rats.
    Martin AF; Paul RJ; McMahon EG
    Hypertension; 1986 Feb; 8(2):128-32. PubMed ID: 2935495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of adrenal hormones (adrenaline and DOCA) in experimental hypertension. A histopathological study.
    Aho AJ; Linna MI; Salmivalli M; Grönroos M; Möttönen M; Paul R
    Res Exp Med (Berl); 1985; 185(4):309-17. PubMed ID: 4048652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension increases connexin43 in a tissue-specific manner.
    Haefliger JA; Castillo E; Waeber G; Bergonzelli GE; Aubert JF; Sutter E; Nicod P; Waeber B; Meda P
    Circulation; 1997 Feb; 95(4):1007-14. PubMed ID: 9054764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated arterial cyclic AMP levels during the development of one-kidney, one-clip and DOCA hypertension in rats.
    Dardik BN; DiBello PM; Chatelain RE
    Eur J Pharmacol; 1988 Dec; 158(1-2):139-43. PubMed ID: 2851454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DOCA-salts induce heart failure in the guinea pig.
    Tiritilli A
    Eur J Heart Fail; 2001 Oct; 3(5):545-51. PubMed ID: 11595602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.